Transjugular Intrahepatic Portosystemic Shunts: Long-term Patency and Clinical Results in a Patient Cohort Observed for 3-9 Years

Radiology

Volumn 231, Issue 2, 2004, Pages 537-545

  Ter Borg, Pieter C J ^a   Hollemans, Mirjam ^a   Van Buuren, Henk R ^a   Vleggaar, Frank P ^a   Groeneweg, Michael ^a   Hop, Wim C J ^a   Laméris, Johan S ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Hypertension, portal; Liver, interventional procedures; Shunts, protosystemic; Stents and prostheses

Indexed keywords

CREATININE;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; ASCITES; COHORT ANALYSIS; CREATININE BLOOD LEVEL; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HUMAN; INTERVENTIONAL RADIOLOGY; KAPLAN MEIER METHOD; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SURVIVAL RATE; THROMBOCYTE COUNT; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; COHORT STUDIES; FEMALE; HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMANS; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; VASCULAR PATENCY;

EID: 2142710951     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2312021797     Document Type: Article

References (60)

1. Rossle M, Siegerstetter V, Huber M, Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt: state of the art. Liver 1998; 18:73-89.
2. Rossle M, Ochs A, Gulberg V, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000; 342:1701-1707.
3. Sanyal AJ, Freedman AM, Luketic VA, et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112:889-898.
4. Richter GM, Palmaz JC, Noldge G, et al. The transjugular intrahepatic portosystemic stent-shunt: a new nonsurgical percutaneous method. Radiologe 1989; 29:406-411.
5. Casado M, Bosch J, Garcia-Pagan JC, et al. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 1998; 114:1296-1303.
6. Meyer KM, Zibari GB, McMillan RW, et al. A retrospective study of the efficacy of transjugular intrahepatic portosystemic shunts. Am Surg 1996; 62:76-80.
7. LaBerge JM, Somberg KA, Lake JR, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995; 108:1143-1151.
8. Gschwantler M, Gebauer A, Rohrmoser M, et al. Clinical outcome 2 years after implantation of a transjugular intrahepatic portosystemic shunt for recurrent variceal bleeding. Eur J Gastroenterol Hepatol 1997; 9:15-20.
9. Saxon RS, Ross PL, Mendel-Hartvig J, et al. Transjugular intrahepatic portosystemic shunt patency and the importance of stenosis location in the development of recurrent symptoms. Radiology 1998; 207:683-693.
10. Sterling KM, Darcy MD. Stenosis of transjugular intrahepatic portosystemic shunts: presentation and management. AJR Am J Roentgenol 1997; 168:239-244.
11. Zhuang ZW, Teng GJ, Jeffery RF, Gemery JM, Janne d'Othee B, Bettmann MA. Long-term results and quality of life in patients treated with transjugular intrahepatic portosystemic shunts. AJR Am J Roentgenol 2002; 179:1597-1603.
12. Borsa JJ, Fontaine AB, Hoffer EK, et al. Retrospective comparison of the patency of Wallstents and Palmaz long-medium stents used for TIPS: transjugular intrahepatic portosystemic shunts. Cardiovasc Intervent Radiol 2000; 23:332-339.
13. Barange K, Peron JM, Imani K, et al. Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology 1999; 30:1139-1143.
14. Latimer J, Bawa SM, Rees CJ, Hudson M, Rose JD. Patency and reintervention rates during routine TIPSS surveillance. Cardiovasc Intervent Radiol 1998; 21:234-239.
15. Peron JM, Barange K, Otal P, et al. Transjugular intrahepatic portosystemic shunts in the treatment of refractory ascites: results in 48 consecutive patients. J Vasc Interv Radiol 2000; 11:1211-1216.
16. Stanley AJ, Jalan R, Forrest EH, Redhead DN, Hayes PC. Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients. Gut 1996; 39:479-485.
17. Textor HJ, Brensing KA, Wilhelm K, et al. TIPSS: Technische und klinische ergebnisse nach 4 jahren. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1998; 168:361-368.
18. Rossle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330:165-171.
19. de Franchis R, Pascal JP, Ancona E, et al. Definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 1992; 15:256-261.
20. de Franchis R. Developing consensus in portal hypertension. J Hepatol 1996; 25:390-394.
21. Opolon P, Rapin JR, Huguet C, et al. Hepatic failure coma (HFC) treated by polyacrylonitrile membrane (PAN) hemodialysis (HD). Trans Am Soc Artif Intern Organs 1976; 22:701-710.
22. van der Heijde RM, Lameris JS, van den Berg B, Wagenvoort CA, Hilvering C, van Buuren HR. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt (TIPS). Eur Respir J 1996; 9:1562-1564.
23. Mercado MA, Orozco H, Guillen-Navarro E, et al. Small-diameter mesocaval shunts: a 10-year evaluation. J Gastrointest Surg 2000; 4:453-457.
24. Rikkers LF, Burnett DA, Volentine GD, Buchi KN, Cormier RA. Shunt surgery versus endoscopic sclerotherapy for long-term treatment of variceal bleeding: early results of a randomized trial. Ann Surg 1987; 206:261-271.
25. Kitano S, Iso Y, Hashizume M, et al. Sclerotherapy vs. esophageal transection vs. distal splenorenal shunt for the clinical management of esophageal varices in patients with child class A and B liver function: a prospective randomized trial. Hepatology 1992; 15:63-68.
26. Fischer JE, Bower RH, Atamian S, Welling R. Comparison of distal and proximal splenorenal shunts: a randomized prospective trial. Ann Surg 1981; 194:531-544.
27. Millikan WJ Jr, Warren WD, Henderson JM, et al. The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding - ten year follow-up. Ann Surg 1985; 201:712-722.
28. Grace ND, Conn HO, Resnick RH, et al. Distal splenorenal vs. portal-systemic shunts after hemorrhage from varices: a randomized controlled trial. Hepatology 1988; 8:1475-1481.
29. Hidajat N, Vogl T, Stobbe H, et al. Transjugular intrahepatic portosystemic shunt: experiences at a liver transplantation center. Acta Radiol 2000; 41:474-478.
30. Owens CA, Bartolone C, Warner DL, et al. The inaccuracy of duplex ultrasonography in predicting patency of transjugular intrahepatic portosystemic shunts. Gastroenterology 1998; 114:975-980.
31. Furst G, Malms J, Heyer T, et al. Transjugular intrahepatic portosystemic shunts: improved evaluation with echo-enhanced color Doppler sonography, power Doppler sonography, and spectral duplex sonography. AJR Am J Roentgenol 1998; 170:1047-1054.
32. Uggowitzer MM, Kugler C, Machan L, et al. Value of echo-enhanced Doppler sonography in evaluation of transjugular intrahepatic portosystemic shunts. AJR Am J Roentgenol 1998; 170:1041-1046.
33. Shah SH, Lui HF, Helmy A, Redhead DN, Penny K, Hayes PC. Transjugular intrahepatic portosystemic stent-shunt insufficiency and the role of diabetes mellitus. Eur J Gastroenterol Hepatol 2001; 13:257-261.
34. Jalan R, Harrison DJ, Redhead DN, Hayes PC. Transjugular intrahepatic portosystemic stent-shunt (TIPSS) occlusion and the role of biliary venous fistulae. J Hepatol 1996; 24:169-176.
35. Sauer P, Theilmann L, Stremmel W, Benz C, Richter GM, Stiehl A. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology 1997; 113:1623-1631.
36. Jalan R, Elton RA, Redhead DN, Finlayson ND, Hayes PC. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 1995; 23:123-128.
37. Zuckerman DA, Darcy MD, Bocchini TP, Hildebolt CF. Encephalopathy after transjugular intrahepatic portosystemic shunting: analysis of incidence and potential risk factors. AJR Am J Roentgenol 1997; 169:1727-1731.
38. Theilmann L, Sauer P, Roeren T, et al. Acetylsalicylic acid in the prevention of early stenosis and occlusion of transjugular intrahepatic portal-systemic stent shunts: a controlled study. Hepatology 1994; 20:592-597.
39. Siegerstetter V, Huber M, Ochs A, Blum HE, Rossle M. Platelet aggregation and platelet-derived growth factor inhibition for prevention of insufficiency of the transjugular intrahepatic portosystemic shunt: a randomized study comparing trapidil plus ticlopidine with heparin treatment. Hepatology 1999; 29:33-38.
40. Vliegenthart R, Geleijnse JM, Hofman A, et al. Alcohol consumption and risk of peripheral arterial disease: the Rotterdam study. Am J Epidemiol 2002; 155:332-338.
41. Walsh CR, Larson MG, Evans JC, et al. Alcohol consumption and risk for congestive heart failure in the Framingham heart study. Ann Intern Med 2002; 136:181-191.
42. Gronbaek M, Deis A, Sorensen TI, Becker U, Schnohr P, Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. BMJ 1995; 310:1165-1169.
43. Pahor M, Guralnik JM, Havlik RJ, et al. Alcohol consumption and risk of deep venous thrombosis and pulmonary embolism in older patients. J Am Geriatr Soc 1996; 44:1030-1037.
44. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339:1523-1526.
45. Haskal ZJ, Davis A, McAllister A, Furth EE. PTFE-encapsulated endovascular stent-graft for transjugular intrahepatic portosystemic shunts: experimental evaluation. Radiology 1997; 205:682-688.
46. Nishimine K, Saxon RR, Kichikawa K, et al. Improved transjugular intrahepatic portosystemic shunt patency with PTFE-covered stent-grafts: experimental results in swine. Radiology 1995; 196:341-347.
47. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346:1773-1780.
48. Cabrera J, Maynar M, Granados R, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1996; 110:832-839.
49. Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP 3rd, Luketic VA, Cheatham AK. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994; 20:46-55.
50. Riggio O, Merlli M, Pedretti G, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: incidence and risk factors. Dig Dis Sci 1996; 41:578-584.
51. Rossle M, Deibert P, Haag K, et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997; 349:1043-1049.
52. Somberg KA, Riegler JL, LaBerge JM, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol 1995; 90:549-555.
53. Groeneweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28:45-49.
54. Forrest EH, Stanley AJ, Redhead DN, McGilchrist AJ, Hayes PC. Clinical response after transjugular intrahepatic portosystemic stent shunt insertion for refractory ascites in cirrhosis. Aliment Pharmacol Ther 1996; 10:801-806.
55. Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332:1192-1197.
56. Rees CJ, Rose JD, Record CO, et al. Transjugular intrahepatic portosystemic shunt: a limited role in refractory ascites. Eur J Gastroenterol Hepatol 1997; 9:969-973.
57. Quiroga J, Sangro B, Nunez M, et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology 1995; 21:986-994.
58. Lebrec D, Giuily N, Hadengue A, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites-a randomized trial. French group of clinicians and a group of biologists. J Hepatol 1996; 25:135-144.
59. Somberg KA, Lake JR, Tomlanovich SJ, LaBerge JM, Feldstein V, Bass NM. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology 1995; 21:709-716.
60. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871.